Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Sarcoma 54Dendritic Cell Sarcoma, Interdigitating 38Lymphoma 37Burkitt Lymphoma 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Large B-Cell, Diffuse 27Leukemia 27Lymphoma, Non-Hodgkin 25Recurrence 24Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Follicular 23Lymphoma, Mantle-Cell 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Acute 21Neuroectodermal Tumors, Primitive, Peripheral 19Hodgkin Disease 19Osteosarcoma 18Multiple Myeloma 18Myeloproliferative Disorders 17Central Nervous System Neoplasms 17Astrocytoma 17Neoplasms, Plasma Cell 16Leukemia, Myeloid, Chronic-Phase 16Rhabdomyosarcoma 15Leukemia, Myeloid, Accelerated Phase 15Blast Crisis 15Ovarian Neoplasms 14Neuroblastoma 13

Interventions

Doxorubicin 4Dexrazoxane 3Methotrexate 2Cisplatin 2pegfilgrastim 1Vincristine 1Rituximab 1Razoxane 1Prednisolone 1Neoadjuvant Therapy 1Leucovorin 1Lenalidomide 1Ifosfamide 1Filgrastim 1Etoposide 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Filgrastim × Sarcoma × Clear all
NCT00019864 2015-06-08

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡